Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lipidor updates on Phase III study of AKP02 in treatment of psoriasis - half of patients now recruited 2022-05-20 14:56
Animal health company Emollivet raises capital and strengthens team 2022-03-15 15:48
Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis 2022-01-26 21:57
Lipidor expands clinical program, announces investment in new drug development project against acne vulgaris 2021-12-17 16:10
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis 2021-09-27 17:37
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70 2021-07-02 05:32
Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova 2021-04-23 15:22
Lipidor - update on the company's phase III clinical trial of drug candidate AKP02 for treatment of psoriasis 2021-04-22 16:02
Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production 2020-12-16 16:12
Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology 2020-09-30 15:44
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis 2020-07-08 14:57
Lipidor AB (publ) Formalizes Relationship With Subsidiary Emollivet AB Through License Agreement and Proposes Financing of Subsidiary 2020-07-01 08:06
New Disinfection Spray From Lipidor and Aurena Laboratories 2020-03-04 15:20
Lipidor Announces Positive Topline Results of AKP01 Phase III Clinical Study Using Calcipotriol Spray Against Psoriasis 2020-01-24 23:21
Lipidor Announces Enrolment of Last Patient in Calcipotriol/AKVANO Spray (AKP01) Phase III Study Targeting Psoriasis 2019-09-09 20:37
1